Cite
MLA Citation
Carlotta Antoniotti et al.. “Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.” Lancet oncology, vol. 23, no. 7, 2022, pp. 876–887. http://access.bl.uk/ark:/81055/vdc_100158010204.0x00003f